---
figid: PMC11125012__pharmaceuticals-17-00635-g010
pmcid: PMC11125012
image_filename: PMC11125012__pharmaceuticals-17-00635-g010.jpg
figure_link: /pmc/articles/PMC11125012/figure/F10/
number: Figure 10
figure_title: Comparative RNA sequencing analysis between MLN4924-treated and control
  groups.
caption: Comparative RNA sequencing analysis between MLN4924-treated and control groups.
  (A) DO enrichment bubble chart of differentially expressed genes. (B) KEGG enrichment
  bubble chart of differentially expressed genes. The size of each bubble signifies
  the degree of enrichment, and its position denotes the significance of the disease
  (pathway) affected by the gene changes
article_title: 'Evaluating the Role of Neddylation Modifications in Kidney Renal Clear
  Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments,
  and RNA Sequencing'
citation: Dequan Liu, et al. Pharmaceuticals (Basel). 2024 May;17(5).
year: '2024'
pub_date: 2024-5-
epub_date: 2024-5-15
doi: 10.3390/ph17050635
journal_title: Pharmaceuticals
journa_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords:
- kidney renal clear cell carcinoma
- neddylation
- GSVA
- RNA sequencing
- MLN4924
- PSMB10
---
